A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis
Clinical trial NCT03633396 · COMPLETED
Trial details
- NCT number
- NCT03633396
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-20
- Primary completion
- 2021-04-23
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.